Extraction, isolation, and concentration of calprotectin antigen (S100A8/S100A9) from granulocytes

被引:7
作者
Nilsen, Tom [1 ,2 ]
Haugen, Siri Helen [1 ]
Larsson, Anders [2 ]
机构
[1] Gentian Technol AS, N-1596 Moss, Norway
[2] Uppsala Univ, Dept Med Sci, Uppsala, Sweden
关键词
antigen purification; calprotectin; chromatography; granulocyte; MRP8; MRP14;
D O I
10.1002/hsr2.35
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Calprotectin is a promising biomarker for granulocyte activation. It is mainly measured in faeces as a marker for inflammatory bowel disease. A limitation is that there is no widely accepted calibrator. Aim To establish a method for purification of calprotectin from human granulocytes that is easily reproducible, reliable, and could contribute to a better agreement between different calprotectin methods. Methods and results Calprotectin was purified from granulocyte extracts using ion-exchange chromatography. The granulocytes were separated from blood bags. The purity was analysed by analysing pixel density of a picture of the sodium dodecyl sulfate polyacrylamide gel electrophoresis and by size exclusion chromatography. The calprotectin concentration of the pure antigen solution was determined using Biuret method. The purity was >95% for 3 preparations, and their concentrations were 1079, 1080, and 1813 mg/L. Conclusion It is possible to reproducibly prepare highly purified calprotectin antigen from human granulocytes. The preparations can be used for preparing calibrators, controls for immunological calprotectin assays, and immunisation for raising antibodies against human calprotectin in hens.
引用
收藏
页数:6
相关论文
共 23 条
[1]   L1, A MAJOR GRANULOCYTE PROTEIN - ISOLATION OF HIGH QUANTITIES OF ITS SUBUNITS [J].
BERNTZEN, HB ;
FAGERHOL, MK .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1990, 50 (07) :769-774
[2]  
Bjarnason Ingvar, 2017, Gastroenterol Hepatol (N Y), V13, P53
[3]   Protein standardization II: Dry mass determination procedure for the determination of the dry mass of a pure protein preparation [J].
Blirup-Jensen, S .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (11) :1090-1097
[4]   The epidemiology of irritable bowel syndrome [J].
Canavan, Caroline ;
West, Joe ;
Card, Timothy .
CLINICAL EPIDEMIOLOGY, 2014, 6 :71-80
[5]   PURIFICATION AND PARTIAL CHARACTERIZATION OF A HIGHLY IMMUNOGENIC HUMAN-LEUKOCYTE PROTEIN, THE L1-ANTIGEN [J].
DALE, I ;
FAGERHOL, MK ;
NAESGAARD, I .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1983, 134 (01) :1-6
[6]   Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease [J].
De Sloovere, Maxime M. W. ;
De Smet, Dieter ;
Baert, Filip J. ;
Debrabandere, Johan ;
Vanpoucke, Hilde J. M. .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2017, 55 (09) :1435-1446
[7]  
Fagerhol MagneK., 1989, PURIFIED HUMAN GRANY
[8]   Variations in assay protocol for the Dako cystatin C method may change patient results by 50% without changing the results for controls [J].
Flodin, Mats ;
Hansson, Lars-Olof ;
Larsson, Anders .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2006, 44 (12) :1481-1485
[9]   Calprotectin as a marker of inflammation in cystic fibrosis [J].
Golden, BE ;
Clohessy, PA ;
Russell, G ;
Fagerhol, MK .
ARCHIVES OF DISEASE IN CHILDHOOD, 1996, 74 (02) :136-139
[10]   Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis [J].
Hammer, H. Berner ;
Odegard, S. ;
Syversen, S. W. ;
Landewe, R. ;
van der Heijde, D. ;
Uhlig, T. ;
Mowinckel, P. ;
Kvien, T. K. .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (01) :150-154